Joinn Laboratories (06127): Abnormal fluctuations in A shares trading of the company with no undisclosed major information that should have been disclosed.

date
18:01 31/03/2026
avatar
GMT Eight
Zhao Yan New Medicine (06127) announced that the closing price of the company's A shares exceeded 20% of the deviation value for three consecutive trading days on March 27, March 30, and March 31, 2026. According to the relevant provisions of the Shanghai Stock Exchange Trading Rules, this situation constitutes abnormal stock trading volatility.
Joinn Laboratories (06127) announced that the closing price of the company's A shares deviated by more than 20% for three consecutive trading days on March 27, March 30, and March 31, 2026. According to the relevant regulations of the Shanghai Stock Exchange trading rules, this constitutes abnormal fluctuation in the stock trading. After conducting self-inspection and written inquiries to the company's controlling shareholder and actual controller, as of the date of this announcement, the company, its controlling shareholder, and actual controller confirmed that there is no material information that should be disclosed but has not been disclosed.